日前,信立泰药业旗下创新药品复立安®(通用名:阿利沙坦酯吲达帕胺缓释片)在京东健康全网首发。该药由信立泰公司独家研发,是中国首个ARNI+噻嗪样利尿剂固定复方制剂原研降压药。它采用三重机制协同降压,实现两单药一快一慢,错峰释放,将为高血压患者带来更优的用药体验。京东健康将充分发挥自身全渠道优势,提升这款药品的可及性,让更多高血压患者从中获益。高血压是一种全身性疾病,可导致脑卒中、冠心病、心力衰竭、...
Source Link日前,信立泰药业旗下创新药品复立安®(通用名:阿利沙坦酯吲达帕胺缓释片)在京东健康全网首发。该药由信立泰公司独家研发,是中国首个ARNI+噻嗪样利尿剂固定复方制剂原研降压药。它采用三重机制协同降压,实现两单药一快一慢,错峰释放,将为高血压患者带来更优的用药体验。京东健康将充分发挥自身全渠道优势,提升这款药品的可及性,让更多高血压患者从中获益。高血压是一种全身性疾病,可导致脑卒中、冠心病、心力衰竭、...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.